[Symptomatic treatment of Raynaud's phenomenon: reserpine, alpha-methyldopa, griseofulvin, guanethidine].
作者信息
Zicot M
出版信息
Rev Med Liege. 1980 Oct 1;35(19):652-4.
PMID:6161403
Abstract
摘要
相似文献
1
[Symptomatic treatment of Raynaud's phenomenon: reserpine, alpha-methyldopa, griseofulvin, guanethidine].
Rev Med Liege. 1980 Oct 1;35(19):652-4.
2
Pharmacologic management of Raynaud's phenomenon.
South Med J. 1984 Sep;77(9):1160-4. doi: 10.1097/00007611-198409000-00027.
3
Griseofulvin in Raynaud's phenomenon.
Lancet. 1971 Nov 13;2(7733):1090. doi: 10.1016/s0140-6736(71)90404-1.
4
A double-blind clinical trial of griseofulvin in patients with Raynaud's phenomenon.
Postgrad Med J. 1973 Sep;49(575):641-3. doi: 10.1136/pgmj.49.575.641.
5
Griseofulvin in Raynaud's phenomenon.
Lancet. 1971 Oct 16;2(7729):840-1. doi: 10.1016/s0140-6736(71)90219-4.
6
Griseofulvin in Raynaud's disease.
Lancet. 1970 Nov 28;2(7683):1136. doi: 10.1016/s0140-6736(70)92330-5.
7
[Griseofulvin administered for an indeterminate time in the therapy of systemic scleroderma and Raynaud's syndrome].
Reumatismo. 1971 Mar-Apr;23(2):82-92.
8
Raynaud's disease treated with griseofulvin.
Arch Dis Child. 1968 Jun;43(229):344-6. doi: 10.1136/adc.43.229.344.
9
[Spasm and Raynaud's phenomenon].
Ann Cardiol Angeiol (Paris). 1981 Mar-Apr;30(2):91-3.
10
Reserpine and Raynaud's phenomenon.
N Engl J Med. 1971 Jul 29;285(5):290-1. doi: 10.1056/NEJM197107292850513.
Zotero 插件